Dr. Andre Paixao, MD
Claim this profileArkansas Heart Hospital
Studies Coronary Artery Disease
Studies Pathologic Constriction
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
More about Andre Paixao, MD
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Andre Paixao, MD has experience with
- Fractional Flow Reserve (FFR)
- Virtual Flow Reserve (VFR)
Breakdown of trials Andre Paixao, MD has run
Coronary Artery Disease
Pathologic Constriction
Coronary Artery Stenosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andre Paixao, MD specialize in?
Andre Paixao, MD focuses on Coronary Artery Disease and Pathologic Constriction. In particular, much of their work with Coronary Artery Disease has involved treating patients, or patients who are undergoing treatment.
Is Andre Paixao, MD currently recruiting for clinical trials?
No, Andre Paixao, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Andre Paixao, MD has studied deeply?
Yes, Andre Paixao, MD has studied treatments such as Fractional Flow Reserve (FFR), Virtual Flow Reserve (VFR).
What is the best way to schedule an appointment with Andre Paixao, MD?
Apply for one of the trials that Andre Paixao, MD is conducting.
What is the office address of Andre Paixao, MD?
The office of Andre Paixao, MD is located at: Arkansas Heart Hospital, Little Rock, Arkansas 72211 United States. This is the address for their practice at the Arkansas Heart Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.